These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8520799)

  • 41. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
    Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of dexamethasone in the context of Toxoplasma gondii infection.
    Zhang J; Qin X; Zhu YU; Zhang S; Zhang XW; Lu HE
    Parasitology; 2017 Sep; 144(11):1551-1559. PubMed ID: 28653591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review on human toxoplasmosis.
    Saadatnia G; Golkar M
    Scand J Infect Dis; 2012 Nov; 44(11):805-14. PubMed ID: 22831461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma.
    Gazzinelli RT; Brézin A; Li Q; Nussenblatt RB; Chan CC
    Exp Parasitol; 1994 Mar; 78(2):217-29. PubMed ID: 8119376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients.
    Meira CS; Vidal JE; Costa-Silva TA; Motoie G; Gava R; Hiramoto RM; Pereira-Chioccola VL
    J Immunol Methods; 2013 Sep; 395(1-2):21-8. PubMed ID: 23811152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental approaches to understanding virulence in toxoplasmosis.
    Sibley LD; Mordue D; Howe DK
    Immunobiology; 1999 Dec; 201(2):210-24. PubMed ID: 10631570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
    Innes EA; Vermeulen AN
    Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluating of Wistar rat and BALB/c mouse as animal models for congenital, cerebral and ocular toxoplasmosis.
    Sharif M; Faridnia R; Sarvi S; Gholami S; Kalani H; Daryani A
    Acta Parasitol; 2018 Dec; 63(4):808-813. PubMed ID: 30367763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis.
    Lu F; Huang S; Kasper LH
    Infect Immun; 2004 Sep; 72(9):4966-72. PubMed ID: 15321988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Toxoplasma gondii: perspectives for a vaccine].
    Gottstein B
    Schweiz Med Wochenschr Suppl; 1995; 65():89S-95S. PubMed ID: 7716458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxoplasma gondii: fluconazole and itraconazole activity against toxoplasmosis in a murine model.
    Martins-Duarte ES; Lemgruber L; de Souza W; Vommaro RC
    Exp Parasitol; 2010 Apr; 124(4):466-9. PubMed ID: 20045696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis.
    Benmerzouga I; Checkley LA; Ferdig MT; Arrizabalaga G; Wek RC; Sullivan WJ
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6939-45. PubMed ID: 26303803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells.
    Lütjen S; Soltek S; Virna S; Deckert M; Schlüter D
    Infect Immun; 2006 Oct; 74(10):5790-801. PubMed ID: 16988257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mic1-3 knockout of Toxoplasma gondii is a successful vaccine against chronic and congenital toxoplasmosis in mice.
    Ismael AB; Dimier-Poisson I; Lebrun M; Dubremetz JF; Bout D; Mevelec MN
    J Infect Dis; 2006 Oct; 194(8):1176-83. PubMed ID: 16991094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.
    Gazzinelli RT; Wysocka M; Hayashi S; Denkers EY; Hieny S; Caspar P; Trinchieri G; Sher A
    J Immunol; 1994 Sep; 153(6):2533-43. PubMed ID: 7915739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum and aqueous humour cytokine response and histopathological alterations during ocular Toxoplasma gondii infection in C57BL/6 mice.
    Calabrese KS; Tedesco RC; Zaverucha do Valle T; Barbosa HS
    Micron; 2008 Dec; 39(8):1335-41. PubMed ID: 18343675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infection and stage conversion during murine pulmonary toxoplasmosis: a study with three different strains of Toxoplasma gondii.
    Sahm M; Gross U; Reiter-Owona I; Seitz HM
    J Parasitol; 1998 Aug; 84(4):723-9. PubMed ID: 9714201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of apoptosis and interferon-gamma in murine toxoplasmosis.
    Shen DF; Matteson DM; Tuaillon N; Suedekum BK; Buggage RR; Chan CC
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2031-6. PubMed ID: 11481268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Depletion of T-4+ lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDS.
    Vollmer TL; Waldor MK; Steinman L; Conley FK
    J Immunol; 1987 Jun; 138(11):3737-41. PubMed ID: 3108372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.